These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 26111032)

  • 1. KDM1 histone lysine demethylases as targets for treatments of oncological and neurodegenerative disease.
    Maes T; Mascaró C; Ortega A; Lunardi S; Ciceri F; Somervaille TC; Buesa C
    Epigenomics; 2015; 7(4):609-26. PubMed ID: 26111032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting the LSD1/KDM1 Family of Lysine Demethylases in Cancer and Other Human Diseases.
    Mao F; Shi YG
    Adv Exp Med Biol; 2023; 1433():15-49. PubMed ID: 37751134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comprehensive review of lysine-specific demethylase 1 and its roles in cancer.
    Hosseini A; Minucci S
    Epigenomics; 2017 Aug; 9(8):1123-1142. PubMed ID: 28699367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural insights into histone lysine demethylation.
    Hou H; Yu H
    Curr Opin Struct Biol; 2010 Dec; 20(6):739-48. PubMed ID: 20970991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting histone lysine demethylases - progress, challenges, and the future.
    Thinnes CC; England KS; Kawamura A; Chowdhury R; Schofield CJ; Hopkinson RJ
    Biochim Biophys Acta; 2014 Dec; 1839(12):1416-32. PubMed ID: 24859458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The emerging role of histone lysine demethylases in prostate cancer.
    Crea F; Sun L; Mai A; Chiang YT; Farrar WL; Danesi R; Helgason CD
    Mol Cancer; 2012 Aug; 11():52. PubMed ID: 22867098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histone demethylases in neurodevelopment and neurodegenerative diseases.
    Wang H; Guo B; Guo X
    Int J Neurosci; 2024 Nov; 134(11):1372-1382. PubMed ID: 37902510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. KDM1A microenvironment, its oncogenic potential, and therapeutic significance.
    Ismail T; Lee HK; Kim C; Kwon T; Park TJ; Lee HS
    Epigenetics Chromatin; 2018 Jun; 11(1):33. PubMed ID: 29921310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lysine Demethylation in Pathogenesis.
    Cao J; Yan Q
    Adv Exp Med Biol; 2023; 1433():1-14. PubMed ID: 37751133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LSD1: more than demethylation of histone lysine residues.
    Perillo B; Tramontano A; Pezone A; Migliaccio A
    Exp Mol Med; 2020 Dec; 52(12):1936-1947. PubMed ID: 33318631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression, Purification, and Biochemical Analysis of the LSD1/KDM1A Histone Demethylase.
    Laurent B; Shi Y
    Methods Enzymol; 2016; 573():241-59. PubMed ID: 27372756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of histone demethylases in cancer therapy.
    Hoffmann I; Roatsch M; Schmitt ML; Carlino L; Pippel M; Sippl W; Jung M
    Mol Oncol; 2012 Dec; 6(6):683-703. PubMed ID: 22902149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting histone demethylases as a potential cancer therapy (Review).
    Diao W; Zheng J; Li Y; Wang J; Xu S
    Int J Oncol; 2022 Sep; 61(3):. PubMed ID: 35801593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cancer driver genes IDH1/2, JARID1C/ KDM5C, and UTX/ KDM6A: crosstalk between histone demethylation and hypoxic reprogramming in cancer metabolism.
    Chang S; Yim S; Park H
    Exp Mol Med; 2019 Jun; 51(6):1-17. PubMed ID: 31221981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A scintillation proximity assay for histone demethylases.
    Yu W; Eram MS; Hajian T; Szykowska A; Burgess-Brown N; Vedadi M; Brown PJ
    Anal Biochem; 2014 Oct; 463():54-60. PubMed ID: 25010373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role and prospect of lysine-specific demethylases in cancer chemoresistance.
    Song YQ; Yang GJ; Ma DL; Wang W; Leung CH
    Med Res Rev; 2023 Sep; 43(5):1438-1469. PubMed ID: 37012609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug discovery of histone lysine demethylases (KDMs) inhibitors (progress from 2018 to present).
    He X; Zhang H; Zhang Y; Ye Y; Wang S; Bai R; Xie T; Ye XY
    Eur J Med Chem; 2022 Mar; 231():114143. PubMed ID: 35101649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histone demethylase LSD1 controls the phenotypic plasticity of cancer cells.
    Hino S; Kohrogi K; Nakao M
    Cancer Sci; 2016 Sep; 107(9):1187-92. PubMed ID: 27375009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro histone demethylase assays.
    Kokura K; Sun L; Fang J
    Methods Mol Biol; 2015; 1288():109-22. PubMed ID: 25827878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Emerging Significance of Histone Lysine Demethylases as Prognostic Markers and Therapeutic Targets in Head and Neck Cancers.
    Dorna D; Paluszczak J
    Cells; 2022 Mar; 11(6):. PubMed ID: 35326475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.